Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rapid Micro Biosystems (RPID) Equity Average (2020 - 2025)

Rapid Micro Biosystems' Equity Average history spans 6 years, with the latest figure at $38.8 million for Q4 2025.

  • On a quarterly basis, Equity Average fell 51.46% to $38.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $38.8 million, a 51.46% decrease, with the full-year FY2025 number at $54.3 million, down 43.85% from a year prior.
  • Equity Average hit $38.8 million in Q4 2025 for Rapid Micro Biosystems, down from $49.4 million in the prior quarter.
  • Over the last five years, Equity Average for RPID hit a ceiling of $227.9 million in Q4 2021 and a floor of -$157.8 million in Q2 2021.
  • Historically, Equity Average has averaged $95.0 million across 5 years, with a median of $106.1 million in 2024.
  • Biggest five-year swings in Equity Average: skyrocketed 432.6% in 2022 and later tumbled 51.46% in 2025.
  • Tracing RPID's Equity Average over 5 years: stood at $227.9 million in 2021, then fell by 24.69% to $171.6 million in 2022, then fell by 28.38% to $122.9 million in 2023, then tumbled by 35.01% to $79.9 million in 2024, then crashed by 51.46% to $38.8 million in 2025.
  • Business Quant data shows Equity Average for RPID at $38.8 million in Q4 2025, $49.4 million in Q3 2025, and $60.0 million in Q2 2025.